AIxCrypto Holdings, Inc. FFR

No quarterly revenue total was found in AIxCrypto Holdings, Inc.'s SEC filings.

AIxCrypto Holdings, Inc. (FFR) files with the SEC under industry code 6199, Finance Services.

Revenue
—
Net income
$-4.19M
-148.5% vs year-ago quarter
Operating cash flow
$-3.44M
-213.7% vs year-ago quarter
Free cash flow
—
EPS
$-0.21
+79.0% vs year-ago quarter
Dividend per share
None
Shares outstanding
20.23M
+1093.5% vs year-ago quarter
Net cash
$1.17M
Q4 FY2024
Operating margin
-195.6%
TTM

Company profile

Industry
Finance Services (SIC 6199)
Listed as
FFR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
El Segundo, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1460702
Former names
AIxCrypto Holdings, Inc. (until Sep 29, 2026); Qualigen Therapeutics, Inc. (until Nov 19, 2025); RITTER PHARMACEUTICALS INC (until May 20, 2020)

Other Finance Services companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Operating income
-$3.0M
-$4.3M
-$7.4M
-$1.4M
-$1.7M
Net income
-$4.2M
-$6.1M
-$10.6M
-$2.0M
-$1.7M
Diluted EPS
-$0.21
-$0.79
-$2.66
-$4.68
-$1.00
Operating cash flow
-$3.4M
-$4.5M
-$2.1M
-$2.1M
-$1.1M
Total assets
$7.4M
$23.9M
$31.3M
$43.5M
$4.0M
Stockholders' equity
$5.7M
$21.9M
$28.0M
$38.5M
-$1.7M
Cash and investments
$577,328
$6.2M
$19.3M
$38.8M
$331,601

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure
Oct 26, 2026 Oct 26, 2026
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
Oct 26, 2026 Oct 23, 2026
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Oct 14, 2026 Oct 14, 2026
8-K Current report
Bylaw or fiscal year change, Regulation FD disclosure
Sep 29, 2026 Sep 29, 2026
8-K Current report
Other events
Sep 29, 2026 Sep 28, 2026
8-K Current report
Officer or director change
Aug 26, 2026 Aug 21, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.